331 related articles for article (PubMed ID: 28408124)
1. Tau Antibody Targeting Pathological Species Blocks Neuronal Uptake and Interneuron Propagation of Tau in Vitro.
Nobuhara CK; DeVos SL; Commins C; Wegmann S; Moore BD; Roe AD; Costantino I; Frosch MP; Pitstick R; Carlson GA; Hock C; Nitsch RM; Montrasio F; Grimm J; Cheung AE; Dunah AW; Wittmann M; Bussiere T; Weinreb PH; Hyman BT; Takeda S
Am J Pathol; 2017 Jun; 187(6):1399-1412. PubMed ID: 28408124
[TBL] [Abstract][Full Text] [Related]
2. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
[TBL] [Abstract][Full Text] [Related]
3. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
Combs B; Hamel C; Kanaan NM
Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
[TBL] [Abstract][Full Text] [Related]
4. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
[TBL] [Abstract][Full Text] [Related]
6. Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy.
Congdon EE; Lin Y; Rajamohamedsait HB; Shamir DB; Krishnaswamy S; Rajamohamedsait WJ; Rasool S; Gonzalez V; Levenga J; Gu J; Hoeffer C; Sigurdsson EM
Mol Neurodegener; 2016 Aug; 11(1):62. PubMed ID: 27578006
[TBL] [Abstract][Full Text] [Related]
7. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.
Takeda S; Wegmann S; Cho H; DeVos SL; Commins C; Roe AD; Nicholls SB; Carlson GA; Pitstick R; Nobuhara CK; Costantino I; Frosch MP; Müller DJ; Irimia D; Hyman BT
Nat Commun; 2015 Oct; 6():8490. PubMed ID: 26458742
[TBL] [Abstract][Full Text] [Related]
8. Assembly of filamentous tau aggregates in human neuronal cells.
Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
[TBL] [Abstract][Full Text] [Related]
10. Minimalistic in vitro systems for investigating tau pathology.
Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
[TBL] [Abstract][Full Text] [Related]
11. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
[TBL] [Abstract][Full Text] [Related]
12. First-in-Rat Study of Human Alzheimer's Disease Tau Propagation.
Smolek T; Jadhav S; Brezovakova V; Cubinkova V; Valachova B; Novak P; Zilka N
Mol Neurobiol; 2019 Jan; 56(1):621-631. PubMed ID: 29770957
[TBL] [Abstract][Full Text] [Related]
13. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
14. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
Guillozet-Bongaarts AL; Cahill ME; Cryns VL; Reynolds MR; Berry RW; Binder LI
J Neurochem; 2006 May; 97(4):1005-14. PubMed ID: 16606369
[TBL] [Abstract][Full Text] [Related]
15. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
16. Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement.
Lee SH; Le Pichon CE; Adolfsson O; Gafner V; Pihlgren M; Lin H; Solanoy H; Brendza R; Ngu H; Foreman O; Chan R; Ernst JA; DiCara D; Hotzel I; Srinivasan K; Hansen DV; Atwal J; Lu Y; Bumbaca D; Pfeifer A; Watts RJ; Muhs A; Scearce-Levie K; Ayalon G
Cell Rep; 2016 Aug; 16(6):1690-1700. PubMed ID: 27475227
[TBL] [Abstract][Full Text] [Related]
17. Immunological memory to hyperphosphorylated tau in asymptomatic individuals.
Pascual G; Wadia JS; Zhu X; Keogh E; Kükrer B; van Ameijde J; Inganäs H; Siregar B; Perdok G; Diefenbach O; Nahar T; Sprengers I; Koldijk MH; der Linden EC; Peferoen LA; Zhang H; Yu W; Li X; Wagner M; Moreno V; Kim J; Costa M; West K; Fulton Z; Chammas L; Luckashenak N; Fletcher L; Holland T; Arnold C; Anthony Williamson R; Hoozemans JJ; Apetri A; Bard F; Wilson IA; Koudstaal W; Goudsmit J
Acta Neuropathol; 2017 May; 133(5):767-783. PubMed ID: 28341999
[TBL] [Abstract][Full Text] [Related]
18. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
[TBL] [Abstract][Full Text] [Related]
19. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.
Kobayashi K; Nakano H; Hayashi M; Shimazaki M; Fukutani Y; Sasaki K; Sugimori K; Koshino Y
J Neurol Sci; 2003 Apr; 208(1-2):17-24. PubMed ID: 12639720
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.
Baker S; Polanco JC; Götz J
J Alzheimers Dis; 2016 Oct; 54(3):1207-1217. PubMed ID: 27567840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
